US2014005243A1PendingUtilityA1
Methods of treating pediatric patients using dexmedetomidine
Est. expiryOct 14, 2031(~5.2 yrs left)· nominal 20-yr term from priority
A61K 31/4164A61P 25/20A61K 9/0019A61K 31/4174
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The presently disclosed subject matter relates to methods of administering an effective amount of dexmedetomidine to a pediatric patient in order to reduce the incidence of neurological damage. More particularly, the presently disclosed subject matter relates to methods of providing sedation or analgesia to a pediatric patient by administering a dexmedetomidine infusion and optionally a loading dose. The dexmedetomidine can be administered before, during, or after surgery.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating a heart disorder in a pediatric patient in need thereof, wherein the method comprises administering dexmedetomidine before, during or after surgery to the pediatric patient;
wherein the dexmedetomidine is administered as a dose consisting essentially of a loading dose at a concentration of between about 0.005 to about 2 μg/kg; and wherein the pediatric patient is greater than 3 years to less than about 17 years of age.
2 . The method of claim 1 , wherein the pediatric patient is intubated.
3 . The method of claim 1 , wherein the dexmedetomidine is administered to the pediatric patient in an intensive care unit.
4 . The method of claim 1 , wherein the dexmedetomidine is parenterally administered.
5 . The method of claim 1 , wherein the dexmedetomidine is administered by an intravenous infusion.
6 . The method of claim 1 , wherein the surgery is heart surgery.
7 . The method of claim 6 , wherein the dexmedetomidine is administered after cardiopulmonary bypass.Join the waitlist — get patent alerts
Track US2014005243A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.